ICD Co., Ltd. (KOSDAQ:040910)
South Korea · Delayed Price · Currency is KRW 4,895.00
-95.00 (-1.90%)
At close: Feb 20, 2026
ICD Co., Ltd. Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 207,325 | 147,616 | 62,274 | 150,945 | 115,769 | 308,965 |
Other Revenue | 0 | 0 | 0 | - | - | - |
| 207,325 | 147,616 | 62,274 | 150,945 | 115,769 | 308,965 | |
Revenue Growth (YoY) | 97.07% | 137.04% | -58.74% | 30.38% | -62.53% | 154.07% |
Cost of Revenue | 186,941 | 150,860 | 69,915 | 135,062 | 92,238 | 225,135 |
Gross Profit | 20,384 | -3,244 | -7,641 | 15,883 | 23,532 | 83,830 |
Selling, General & Admin | 26,429 | 19,944 | 19,326 | 18,017 | 17,350 | 30,687 |
Research & Development | 1,435 | 1,435 | 1,105 | 1,270 | 1,256 | 661.43 |
Amortization of Goodwill & Intangibles | 257.01 | 257.01 | 433.24 | 429.94 | 395.29 | 294.47 |
Other Operating Expenses | 378.29 | 378.29 | 691.79 | 281.79 | 287.82 | -247.07 |
Operating Expenses | 30,120 | 23,635 | 31,613 | 21,010 | 21,821 | 33,762 |
Operating Income | -9,737 | -26,880 | -39,254 | -5,127 | 1,711 | 50,068 |
Interest Expense | -2,349 | -2,349 | -1,402 | -1,293 | -242.45 | -502.92 |
Interest & Investment Income | 442.91 | 442.91 | 563.56 | 511.2 | 365.12 | 161.01 |
Earnings From Equity Investments | -304.77 | -304.77 | -1,739 | - | -504.62 | -432.76 |
Currency Exchange Gain (Loss) | 5,135 | 5,135 | 1,648 | 4,908 | 3,876 | -6,205 |
Other Non Operating Income (Expenses) | -8,769 | 5,869 | -5,301 | 693.72 | -1,079 | -40.86 |
EBT Excluding Unusual Items | -15,581 | -18,087 | -45,485 | -306.85 | 4,126 | 43,047 |
Gain (Loss) on Sale of Investments | 979.9 | -210.11 | -228.89 | -253.89 | -114.82 | -477.66 |
Gain (Loss) on Sale of Assets | 268.95 | 268.95 | 199.69 | -5.53 | 100 | 44.95 |
Asset Writedown | -4,314 | -4,314 | -833.11 | -4,776 | -3,684 | - |
Other Unusual Items | 952.01 | 952.01 | 633.09 | - | - | - |
Pretax Income | -17,695 | -21,390 | -45,714 | -5,342 | 427.19 | 42,615 |
Income Tax Expense | 6,954 | 6,912 | -4,396 | 76.86 | -334.62 | 9,156 |
Earnings From Continuing Operations | -24,649 | -28,302 | -41,318 | -5,419 | 761.81 | 33,459 |
Minority Interest in Earnings | 64.94 | 11.64 | - | - | - | - |
Net Income | -24,584 | -28,291 | -41,318 | -5,419 | 761.81 | 33,459 |
Net Income to Common | -24,584 | -28,291 | -41,318 | -5,419 | 761.81 | 33,459 |
Net Income Growth | - | - | - | - | -97.72% | 200.03% |
Shares Outstanding (Basic) | 17 | 16 | 16 | 16 | 17 | 17 |
Shares Outstanding (Diluted) | 17 | 16 | 16 | 16 | 17 | 17 |
Shares Change (YoY) | 15.44% | 1.16% | 0.72% | -4.67% | -1.58% | 7.08% |
EPS (Basic) | -1408.63 | -1737.52 | -2566.94 | -339.11 | 45.44 | 2005.31 |
EPS (Diluted) | -1409.08 | -1738.00 | -2567.00 | -339.11 | 45.00 | 1974.05 |
EPS Growth | - | - | - | - | -97.72% | 181.60% |
Free Cash Flow | 10,149 | -30,789 | -7,560 | -22,862 | 17,258 | 46,915 |
Free Cash Flow Per Share | 581.53 | -1890.98 | -469.66 | -1430.56 | 1029.41 | 2754.34 |
Gross Margin | 9.83% | -2.20% | -12.27% | 10.52% | 20.33% | 27.13% |
Operating Margin | -4.70% | -18.21% | -63.03% | -3.40% | 1.48% | 16.20% |
Profit Margin | -11.86% | -19.16% | -66.35% | -3.59% | 0.66% | 10.83% |
Free Cash Flow Margin | 4.90% | -20.86% | -12.14% | -15.15% | 14.91% | 15.19% |
EBITDA | -3,637 | -20,445 | -32,372 | 1,438 | 8,731 | 56,823 |
EBITDA Margin | -1.75% | -13.85% | -51.98% | 0.95% | 7.54% | 18.39% |
D&A For EBITDA | 6,099 | 6,435 | 6,882 | 6,565 | 7,020 | 6,754 |
EBIT | -9,737 | -26,880 | -39,254 | -5,127 | 1,711 | 50,068 |
EBIT Margin | -4.70% | -18.21% | -63.03% | -3.40% | 1.48% | 16.20% |
Effective Tax Rate | - | - | - | - | - | 21.49% |
Advertising Expenses | - | - | 2 | - | 3 | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.